Low Serum Creatine Kinase Levels in Breast Cancer Patients: A Case-Control Study

Background Previous studies provide an ambiguous picture of creatine kinase (CK) expression and activities in malignancy. The aim of this study was to investigate the role of serum CK level in breast cancer patients. Patients and Methods 823 female patients diagnosed with breast cancer were consecutively recruited as cases, and 823 age-match patients with benign breast disease were selected as controls. Serum CK was analyzed by commercially available standardized methods. Results Serum CK level was significantly associated with breast cancer (P = 0.005) and subtypes of breast cancer, including breast cancer with diameter>2 cm (P = 0.031) and stage IIIbreast cancer (P = 0.025). The mean serum CK level in patients with>2 cm tumor was significantly lower than that in≤2 cm (P = 0.0475), and the mean serum CK level of stage III breast cancer patients was significantly lower than that of stage I and II breast cancer patients (P = 0.0246). Furthermore, a significant difference (P = 0.004) was observed between serum CK level and ERBB2+breast cancer not other molecular subtypes. Conclusions Serum CK levels in cases was significantly lower compared with controls. Notably, our results indicated for the first time that there was a negative correlation between serum CK levels and breast cancer stage. Serum CK level, which may reflect the status of host immunity, may be an important factor in determining breast cancer development and progression.

[1]  I. Fentiman,et al.  Inflammation and breast cancer , 2013 .

[2]  Xuan-xian Peng,et al.  Amphioxus CaVPT and creatine kinase are crucial immune-related molecules in response to bacterial infection and immunization. , 2012, Fish & shellfish immunology.

[3]  I. Jatoi,et al.  The global breast cancer burden. , 2012, Future oncology.

[4]  S. Patra,et al.  A short review on creatine–creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapy , 2011, Amino Acids.

[5]  Ahmedin Jemal,et al.  Breast cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[6]  Hai-Meng Zhou,et al.  Slow skeletal muscle myosin-binding protein-C (MyBPC1) mediates recruitment of muscle-type creatine kinase (CK) to myosin. , 2011, The Biochemical journal.

[7]  D. Cramer,et al.  Epidemiologic perspective on immune-surveillance in cancer. , 2011, Current opinion in immunology.

[8]  Theo Wallimann,et al.  The creatine kinase system and pleiotropic effects of creatine , 2011, Amino Acids.

[9]  M. Caligiuri,et al.  Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.

[10]  D. Evans,et al.  Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.

[11]  Shicui Zhang,et al.  Creatine kinase is a bacteriostatic factor with a lectin-like activity. , 2009, Molecular immunology.

[12]  M. Kuum,et al.  Energetic state is a strong regulator of sarcoplasmic reticulum Ca2+ loss in cardiac muscle: different efficiencies of different energy sources. , 2009, Cardiovascular research.

[13]  F. Oerlemans,et al.  Mice lacking brain-type creatine kinase activity show defective thermoregulation , 2009, Physiology & Behavior.

[14]  Xiaolong Liu,et al.  Regulation of T Cell Development and Activation by Creatine Kinase B , 2009, PloS one.

[15]  S. Patra,et al.  Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma , 2008, The FEBS journal.

[16]  Xuan-xian Peng,et al.  Proteomic approach for caudal trauma-induced acute phase proteins reveals that creatine kinase is a key acute phase protein in amphioxus humoral fluid. , 2007, Journal of proteome research.

[17]  L. Coussens,et al.  Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression , 2007, Breast Cancer Research.

[18]  Hai-Meng Zhou,et al.  The Generation of the Oxidized Form of Creatine Kinase Is a Negative Regulation on Muscle Creatine Kinase* , 2007, Journal of Biological Chemistry.

[19]  T. Onda,et al.  Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma , 2006, British Journal of Cancer.

[20]  Mathias Hoehn,et al.  Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation , 2005, NMR in biomedicine.

[21]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[22]  Masahiko Watanabe,et al.  Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK‐Mi and CK‐B suggest a novel neuron–glial relationship for brain energy homeostasis , 2004, The European journal of neuroscience.

[23]  D Hölzel,et al.  The process of metastasisation for breast cancer. , 2003, European journal of cancer.

[24]  B. Delahunt,et al.  Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor. , 2001, American journal of clinical pathology.

[25]  Adelbert Ames,et al.  CNS energy metabolism as related to function , 2000, Brain Research Reviews.

[26]  M. Wyss,et al.  Creatine and creatinine metabolism. , 2000, Physiological reviews.

[27]  P. Fernández,et al.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma , 1999, British Journal of Cancer.

[28]  D. Braun,et al.  Functional analysis of tumor-infiltrating leukocytes in breast cancer patients. , 1998, The Journal of surgical research.

[29]  Y. Kinoshita,et al.  Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.

[30]  J Benichou,et al.  Proportion of breast cancer cases in the United States explained by well-established risk factors. , 1995, Journal of the National Cancer Institute.

[31]  T. Eberlein,et al.  Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Hemmer,et al.  Creatine kinase in non-muscle tissues and cells , 1994, Molecular and Cellular Biochemistry.

[33]  V. Kosma,et al.  Lymphocyte infiltrates as a prognostic variable in female breast cancer. , 1992, European journal of cancer.

[34]  A. Wu,et al.  Reassessment of creatine kinase BB as a marker for cancer of the prostate, breast, and lung. , 1987, Clinical chemistry.

[35]  K. Biemann,et al.  Two tissue-specific isozymes of creatine kinase have closely matched amino acid sequences. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Tsukada,et al.  The uptake of creatine by various tissues from a mouse bearing tumor cells. , 1984, Biochimica et biophysica acta.

[37]  S. Tsung.  Creatine kinase activity and isoenzyme pattern in various normal tissues and neoplasms. , 1983, Clinical chemistry.

[38]  K. Tsukada,et al.  Decreased activities of glycine and guanidinoacetate methyltransferases and increased levels of creatine in tumor cells. , 1982, Biochemical and biophysical research communications.

[39]  H. Eppenberger,et al.  Localization of creatine kinase isoenzymes in myofibrils. I. Chicken skeletal muscle , 1977, The Journal of cell biology.

[40]  H. Eppenberger,et al.  Localization of creatine kinase isoenzymes in myofibrils. II. Chicken heart muscle , 1977, The Journal of cell biology.

[41]  J. Dinning,et al.  An elevated excretion of creatine associated with leukemia in mice. , 1951, Science.

[42]  A. Jemal,et al.  Breast cancer statistics, 2013 , 2014, CA: a cancer journal for clinicians.

[43]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[44]  Lisa M. Coussens,et al.  Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression , 2007 .

[45]  S. Hubbard,et al.  Protein tyrosine kinase structure and function. , 2000, Annual review of biochemistry.

[46]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[47]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[48]  J. Carreras,et al.  Creatine kinase activity and isoenzymes in lung, colon and liver carcinomas. , 1997, British Journal of Cancer.

[49]  J. Gralow,et al.  Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. , 1996, Blood.

[50]  M. Wyss,et al.  Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. , 1992, The Biochemical journal.

[51]  L. Bassalyk,et al.  [Creatine kinase and its isoenzymes in breast tumor tissue]. , 1986, Eksperimental'naia onkologiia.

[52]  Bassalyk Ls,et al.  Creatine kinase and its isoenzymes in breast tumor tissue , 1986 .

[53]  J. Knowles.  Enzyme-catalyzed phosphoryl transfer reactions. , 1980, Annual review of biochemistry.